ADANIR, H. Et Al. 2022. Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result. AASLD-TASL digital Hepatology Connect .

ADANIR, H., ÖZER ETİK, D., YILDIRIM, A. E., YAPALI, S., ARI, D., GÖKCAN, H., ... KIYICI, M.(2022). Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result . AASLD-TASL digital Hepatology Connect

ADANIR, HAYDAR Et Al. "Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result," AASLD-TASL digital Hepatology Connect, 2022

ADANIR, HAYDAR Et Al. "Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result." AASLD-TASL digital Hepatology Connect , 2022

ADANIR, H. Et Al. (2022) . "Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result." AASLD-TASL digital Hepatology Connect .

@conferencepaper{conferencepaper, author={HAYDAR ADANIR Et Al. }, title={Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result}, congress name={AASLD-TASL digital Hepatology Connect}, city={}, country={}, year={2022}}